Your browser doesn't support javascript.
loading
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.
Hickman, Amber; Koetsier, Joost; Kurtanich, Trevin; Nielsen, Michael C; Winn, Glenn; Wang, Yunfei; Bentebibel, Salah-Eddine; Shi, Leilei; Punt, Simone; Williams, Leila; Haymaker, Cara; Chesson, Charles B; Fa'ak, Faisal; Dominguez, Ana L; Jones, Richard; Kuiatse, Isere; Caivano, Amy R; Khounlo, Sayadeth; Warier, Navin D; Marathi, Upendra; Market, Robert V; Biediger, Ronald J; Craft, John W; Hwu, Patrick; Davies, Michael A; Woodside, Darren G; Vanderslice, Peter; Diab, Adi; Overwijk, Willem W; Hailemichael, Yared.
Affiliation
  • Hickman A; Department of Melanoma Medical Oncology.
  • Koetsier J; Department of Melanoma Medical Oncology.
  • Kurtanich T; Department of Melanoma Medical Oncology.
  • Nielsen MC; Department of Melanoma Medical Oncology.
  • Winn G; Department of Melanoma Medical Oncology.
  • Wang Y; Department of Melanoma Medical Oncology.
  • Bentebibel SE; Department of Melanoma Medical Oncology.
  • Shi L; Department of Melanoma Medical Oncology.
  • Punt S; Department of Melanoma Medical Oncology.
  • Williams L; Department of Melanoma Medical Oncology.
  • Haymaker C; Department of Translational Molecular Pathology, and.
  • Chesson CB; Department of Melanoma Medical Oncology.
  • Fa'ak F; Department of Melanoma Medical Oncology.
  • Dominguez AL; Department of Melanoma Medical Oncology.
  • Jones R; Department of Lymphoma Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kuiatse I; Department of Lymphoma Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Caivano AR; Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, Texas, USA.
  • Khounlo S; Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, Texas, USA.
  • Warier ND; Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, Texas, USA.
  • Marathi U; 7 Hills Pharma, Houston, Texas, USA.
  • Market RV; Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, Texas, USA.
  • Biediger RJ; Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, Texas, USA.
  • Craft JW; Department of Biology and Chemistry, University of Houston, Houston, Texas, USA.
  • Hwu P; Department of Melanoma Medical Oncology.
  • Davies MA; Department of Melanoma Medical Oncology.
  • Woodside DG; Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, Texas, USA.
  • Vanderslice P; Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, Texas, USA.
  • Diab A; Department of Melanoma Medical Oncology.
  • Overwijk WW; Department of Melanoma Medical Oncology.
  • Hailemichael Y; Department of Melanoma Medical Oncology.
J Clin Invest ; 132(13)2022 07 01.
Article in En | MEDLINE | ID: mdl-35552271
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Function-Associated Antigen-1 / Melanoma Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Function-Associated Antigen-1 / Melanoma Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Country of publication: Estados Unidos